BlackRock Fund Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $10.4M | Buy |
438,231
+54,463
| +14% | +$1.3M | ﹤0.01% | 2549 |
|
|
2016
Q3 | $14.1M | Buy |
383,768
+26,195
| +7% | +$961K | ﹤0.01% | 2261 |
|
|
2016
Q2 | $7.97M | Buy |
357,573
+14,787
| +4% | +$330K | ﹤0.01% | 2535 |
|
|
2016
Q1 | $7.13M | Buy |
342,786
+5,213
| +2% | +$108K | ﹤0.01% | 2552 |
|
|
2015
Q4 | $10.2M | Buy |
337,573
+109,991
| +48% | +$3.33M | ﹤0.01% | 2429 |
|
|
2015
Q3 | $5.62M | Sell |
227,582
-2,643
| -1% | -$65.3K | ﹤0.01% | 2732 |
|
|
2015
Q2 | $7.39M | Sell |
230,225
-7,037
| -3% | -$226K | ﹤0.01% | 2680 |
|
|
2015
Q1 | $8.47M | Sell |
237,262
-3,057
| -1% | -$109K | ﹤0.01% | 2529 |
|
|
2014
Q4 | $5.46M | Sell |
240,319
-76,629
| -24% | -$1.74M | ﹤0.01% | 2826 |
|
|
2014
Q3 | $6.15M | Sell |
316,948
-8,801
| -3% | -$171K | ﹤0.01% | 2622 |
|
|
2014
Q2 | $11.8M | Sell |
325,749
-24,448
| -7% | -$887K | ﹤0.01% | 2318 |
|
|
2014
Q1 | $13.6M | Buy |
350,197
+8,392
| +2% | +$326K | ﹤0.01% | 2220 |
|
|
2013
Q4 | $9.74M | Sell |
341,805
-75,534
| -18% | -$2.15M | ﹤0.01% | 2409 |
|
|
2013
Q3 | $14.9M | Buy |
417,339
+31,991
| +8% | +$1.15M | 0.01% | 2120 |
|
|
2013
Q2 | $12.9M | Buy |
+385,348
| New | +$12.9M | ﹤0.01% | 2117 |
|